• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清神经调节蛋白-1 与 2 型糖尿病致动脉粥样硬化指数的关系。

The link between serum neuregulin-1 and atherogenic index in type 2 diabetes mellitus.

机构信息

Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Department of Chemistry, College of Science, University of Diyala, Baquba, Diyala, Iraq.

出版信息

Ir J Med Sci. 2024 Oct;193(5):2209-2216. doi: 10.1007/s11845-024-03711-8. Epub 2024 May 15.

DOI:10.1007/s11845-024-03711-8
PMID:38748196
Abstract

BACKGROUND

Neuregulin-1(NRG-1) is a protein that belongs to the group of epidermal growth factors. It plays vital roles in anti-fibrotic effects on the myocardium. The current paper explores the role of NRG-1 in type 2 diabetes mellitus (T2DM) and its relation to atherogenic index as a factor for increasing cardiovascular disease(CVD) risk.

MATERIAL AND METHODS

In this study, 79 diabetes mellitus patients are independent insulin. These patients consisted of 53 females and 26 males their age were ranged 40-67 years. They were divided into two groups depending on the atherogenic index of plasma (AIP). Group I including48 diabetic patient with high risk of CVD and group II including 31 diabetic patients without risk CVD. Forty healthy individuals were included as control.

RESULT

When compared to the control group, the serum levels of NRG-1 were significantly lower (p = 0.01). Additionally, group I had a much lower NRG-1level than group II. The results of multiple stepwise regression showed that the only independent predictor for NRG-1 level prediction was AIP (β =  - 0.600, P = 0.040). When comparing the diabetic patients with high risk factors for CVD to the healthy subject group, the AUC was outstanding (AUC = 0.889, P = 0.001) and had a high diagnosis.

CONCLUSIONS

We proved low NRG-1 levels in diabetic patients and the association of highest NRG-1 amounts to a better AIP. Moreover, the measurement of NRG-1 levels could be beneficial as laboratory markers to monitor for increasing CVD risk in type 2 diabetes mellitus.

摘要

背景

神经调节蛋白 1(NRG-1)是一种属于表皮生长因子族的蛋白质。它在心肌抗纤维化作用中发挥着重要作用。本论文探讨了 NRG-1 在 2 型糖尿病(T2DM)中的作用及其与动脉粥样硬化指数(AIP)的关系,AIP 是增加心血管疾病(CVD)风险的一个因素。

材料与方法

在这项研究中,79 名独立使用胰岛素的糖尿病患者,其中 53 名女性,26 名男性,年龄在 40-67 岁之间。根据血浆 AIP 将这些患者分为两组。第一组包括 48 名有 CVD 高风险的糖尿病患者,第二组包括 31 名无 CVD 风险的糖尿病患者。40 名健康个体作为对照组。

结果

与对照组相比,NRG-1 的血清水平明显降低(p=0.01)。此外,第一组的 NRG-1 水平明显低于第二组。多元逐步回归分析结果表明,NRG-1 水平的唯一独立预测因子是 AIP(β=-0.600,P=0.040)。当将 CVD 高危因素的糖尿病患者与健康受试者组进行比较时,AUC 非常出色(AUC=0.889,P=0.001),且具有较高的诊断价值。

结论

我们证明了糖尿病患者 NRG-1 水平较低,并且 NRG-1 水平最高与更好的 AIP 相关。此外,NRG-1 水平的测量可能作为实验室标志物有助于监测 2 型糖尿病患者 CVD 风险的增加。

相似文献

1
The link between serum neuregulin-1 and atherogenic index in type 2 diabetes mellitus.血清神经调节蛋白-1 与 2 型糖尿病致动脉粥样硬化指数的关系。
Ir J Med Sci. 2024 Oct;193(5):2209-2216. doi: 10.1007/s11845-024-03711-8. Epub 2024 May 15.
2
Serum neuregulin 1 in relation to ventricular function and subclinical atherosclerosis in type 2 diabetes patients.2 型糖尿病患者血清神经调节蛋白 1 与心室功能和亚临床动脉粥样硬化的关系。
Endocrinol Diabetes Nutr (Engl Ed). 2023 Dec;70(10):619-627. doi: 10.1016/j.endien.2023.11.010.
3
Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.载脂蛋白相关指数与 2 型糖尿病患者体脂水平相关。
Curr Vasc Pharmacol. 2018;16(6):589-595. doi: 10.2174/1570161116666180103125456.
4
Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.探讨天冬酰胺酶原(asprosin)和神经调节蛋白-4(Nrg-4)与 2 型糖尿病合并冠心病的相关性及其诊断价值。
BMC Endocr Disord. 2023 Mar 13;23(1):61. doi: 10.1186/s12902-023-01311-8.
5
Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus?神经调节蛋白-4 是 2 型糖尿病微血管并发症的预测标志物吗?
Eur J Clin Invest. 2020 Mar;50(3):e13206. doi: 10.1111/eci.13206. Epub 2020 Feb 15.
6
Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data.超重和肥胖患者的血浆致动脉粥样硬化指数与 2 型糖尿病之间的非线性关系:来自中国体检数据的证据。
Cardiovasc Diabetol. 2024 Jun 29;23(1):226. doi: 10.1186/s12933-024-02330-y.
7
Associations between serum vitamin D, atherogenic indices of plasma and cardiometabolic biomarkers among patients with diabetes in the KERCADR study.在 KERCADR 研究中,糖尿病患者血清维生素 D 与血浆致动脉粥样硬化指数及代谢生物标志物的相关性。
BMC Endocr Disord. 2022 May 12;22(1):126. doi: 10.1186/s12902-022-01043-1.
8
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.血浆致动脉粥样硬化指数与 2 型糖尿病患者的主要不良心血管事件相关。
Cardiovasc Diabetol. 2021 Oct 5;20(1):201. doi: 10.1186/s12933-021-01393-5.
9
The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.血浆致动脉粥样硬化指数在预测行经皮冠状动脉介入治疗的 2 型糖尿病患者的预后中发挥重要作用:来自中国观察性队列研究的结果。
Cardiovasc Diabetol. 2020 Feb 21;19(1):23. doi: 10.1186/s12933-020-0989-8.
10
Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population‑based cohort study.载脂蛋白相关指数与全因死亡率和特定原因死亡率的关系:一项全国范围内基于人群的队列研究。
Cardiovasc Diabetol. 2024 Jul 27;23(1):276. doi: 10.1186/s12933-024-02370-4.

引用本文的文献

1
Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease.血浆中神经调节蛋白-1水平降低与动脉粥样硬化性心血管疾病患者的不良预后相关。
Front Cardiovasc Med. 2025 Jul 17;12:1600480. doi: 10.3389/fcvm.2025.1600480. eCollection 2025.
2
Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside.治疗代谢功能障碍相关脂肪性肝病的分泌蛋白:从 bench 到 bedside
Protein Cell. 2025 Aug 7;16(8):641-666. doi: 10.1093/procel/pwaf027.

本文引用的文献

1
Serum neuregulin 1 in relation to ventricular function and subclinical atherosclerosis in type 2 diabetes patients.2 型糖尿病患者血清神经调节蛋白 1 与心室功能和亚临床动脉粥样硬化的关系。
Endocrinol Diabetes Nutr (Engl Ed). 2023 Dec;70(10):619-627. doi: 10.1016/j.endien.2023.11.010.
2
Nesfatin-1 - as a diagnosis regulatory peptide in type 2 diabetes mellitus.Nesfatin-1——作为2型糖尿病的一种诊断调节肽。
J Diabetes Metab Disord. 2022 Jun 18;21(2):1369-1375. doi: 10.1007/s40200-022-01070-8. eCollection 2022 Dec.
3
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.
血浆致动脉粥样硬化指数与 2 型糖尿病患者的主要不良心血管事件相关。
Cardiovasc Diabetol. 2021 Oct 5;20(1):201. doi: 10.1186/s12933-021-01393-5.
4
Clinical significance of serum concentrations of neuregulin-4, in acute coronary syndrome.神经调节蛋白-4 血清浓度在急性冠状动脉综合征中的临床意义。
Sci Rep. 2020 Apr 2;10(1):5797. doi: 10.1038/s41598-020-62680-x.
5
Neuregulin in Health and Disease.健康与疾病中的神经调节蛋白
Int J Brain Disord Treat. 2018;4(1). doi: 10.23937/2469-5866/1410024. Epub 2018 Nov 10.
6
HPLC-based Measurement of Glycated Hemoglobin using Dried Blood Spots Collected under Adverse Field Conditions.基于高效液相色谱法,使用在恶劣现场条件下采集的干血斑测定糖化血红蛋白
Biodemography Soc Biol. 2018 Jan-Mar;64(1):43-62. doi: 10.1080/19485565.2018.1451300.
7
Neuregulin-1 attenuates stress-induced vascular senescence.神经调节蛋白-1 可减轻应激诱导的血管衰老。
Cardiovasc Res. 2018 Jun 1;114(7):1041-1051. doi: 10.1093/cvr/cvy059.
8
Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice.神经调节蛋白 1 可改善健康和糖尿病小鼠骨骼肌中介导的线粒体呼吸复合物 2。
Sci Rep. 2017 May 11;7(1):1742. doi: 10.1038/s41598-017-02029-z.
9
Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults.循环神经调节蛋白 4 水平与肥胖成年人亚临床心血管疾病呈负相关。
Sci Rep. 2016 Nov 7;6:36710. doi: 10.1038/srep36710.
10
A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease.一项病例对照研究:血清神经调节蛋白 4 水平与非酒精性脂肪性肝病的关系。
Metabolism. 2015 Dec;64(12):1667-73. doi: 10.1016/j.metabol.2015.08.013. Epub 2015 Aug 28.